CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
StemTek is creating a user-friendly 3D spheroid culture system for drug testing in cancer treatment. This innovation aims to streamline the drug development process, making it more efficient and accessible for pharmaceutical companies.
StemTek is a global biopharmaceutical company with a clear stem cell focus in drug development for cancer treatment.
Only about 10% of the candidate compounds progress successfully through clinical development.
Many drugs fail during clinical trials, especially during phase III, which is the most expensive phase of clinical development, largely due to the lack of clinical efficacy and/or unacceptable toxicity.
StemTek is developing a solution to make cell based assays a commodity: easy to get,…
STEMTEK THERAPEUTICS SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
